January 19, 2026
The anti-aging market size is forecast to grow from USD 84.41 billion in 2026 to USD 137.13 billion by 2035, g...
Read MoreJune 04, 2026
The simulators market size is forecast to increase from USD 14.71 billion in 2026 to USD 27.59 billion by 2035...
Read MoreJuly 24, 2026
The U.S. behavioral health market is projected to expand from USD 101.84 billion in 2026 to USD 159.35 billion...
Read MoreJanuary 19, 2026
The U.S. digital health market size is forecast to increase from USD 98.69 billion in 2026 to USD 266.5 billio...
Read MoreApril 21, 2026
According to market projections, the global immune repertoire sequencing market, valued at USD 337.43 million in 2024, is anticipated to reach USD 842.44 million by 2034, growing at a CAGR of 9.64% over the next decade. The increasing demand for a variety of therapies and the expansion of R&D are fueling the global market. North America led t...
April 21, 2026
Market insights predict the global cell and gene therapy clinical trials industry will increase from USD 10.8 billion in 2024 to USD 45.31 billion by 2034, achieving a CAGR of 15.43%. Advancements in technologies such as gene editing, CAR-T therapy, and CRISPR-Cas9 have enabled the healthcare sector to address and fulfill the unmet medical needs ...
April 21, 2026
Projections indicate that, the global cellular immunotherapy market will increase from USD 11.33 billion in 2024 to USD 85.78 billion by 2034, experiencing a CAGR of 22.45% over the next 10 years. The increasing investments in R&D activities, rapid advancements in cell engineering, supportive government framework, and rising prevalence o...
April 21, 2026
According to market projections, the single cell sequencing sector is expected to grow from USD 1.63 billion in 2024 to USD 6.65 billion by 2034, reflecting a CAGR of 15.05%. Advancements in sequencing technologies and increased funding for personalized medicine are further driving its expansion....
April 21, 2026
Market insights predict, the gene transfer technologies industry is expected to grow from USD 3.98 billion in 2024 to USD 9.97 billion by 2034, driven by a CAGR of 9.62%. These techniques play a vital role in gene therapy, biotechnology research, and the development of genetically modified ...
April 21, 2026
According to market projections, the bioconjugation sector is expected to grow from USD 5.52 billion in 2024 to USD 23.18 billion by 2034, reflecting a CAGR of 15.46%. Bioconjugation is playing a vital role in next-generation diagnostic tools such as biosensors, imaging agents, and immunoassays. The demand for early and accurate disease detection i...
April 21, 2026
According to forecasts, the global endoscopic submucosal dissection (ESD) market will grow from USD 460 million in 2024 to USD 1022.86 million by 2034, with an expected CAGR of 8.35%. The rising prevalence of gastrointestinal disorders and technological advancements drive the global market. The Asia-Pacific region dominated the global market due ...
April 21, 2026
Projections indicate that, the global oral rinses market will increase from USD 4.12 billion in 2024 to USD 7.7 billion by 2034, experiencing a CAGR of 6.46% over the next 10 years.The increased focus of people on addressing specific oral conditions to prevent and manage them effectively increases the demand for various kinds of mouthwashes in th...
April 21, 2026
Market insights predict the global orthopedic braces & supports industry will increase from USD 4.09 billion in 2025 to USD 7.65 billion by 2035, achieving a CAGR of 6.46%. The orthopedic braces & supports market is growing because it is a type of medical device which are used for injury prevention, rehabilitation and post-surgical recovery...
April 21, 2026
Market insights predict, the digital PCR (dPCR) and real-time PCR (qPCR) industry is expected to grow from USD 10.15 billion in 2024 to USD 21.87 billion by 2034, driven by a CAGR of 7.97%. The digital PCR (dPCR) and real-time PCR (qPCR) market is growing due to rising demand for gene sequencing and the development of gene therapies. North America ...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
